Once CAV has developed, pharmacologic options to halt progression are limited. Moreover, outcomes resulting from available treatment have been disappointing. Retransplantation is the only definitive treatment of established CAV. Ideal regimen should not affect the lipid profile, blood pressures and renal function, and should have a positive impact on hemodynamics.
Cardiac allograft vasculopathy medical therapy
Heart transplantation immunosuppressive therapy
Cardiac amyloidosis surgery
Cardiac amyloidosis medical therapy
Atherosclerosis medical therapy
Goodpasture syndrome medical therapy
Dilated cardiomyopathy medical therapy
Uveitis medical therapy